Gilead Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2011
Total Assets: $17.30B
Liabilities Breakdown FY2011
Total Liabilities: $10.56B
Asset Breakdown
Total Assets: $17.30B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.88B | 57.1% |
| Accounts Receivable | $1.95B | 11.3% |
| Inventory | $1.39B | 8.0% |
| Property, Plant & Equipment | $774.4M | 4.5% |
| Goodwill | $1.00B | 5.8% |
| Intangible Assets | $1.06B | 6.1% |
| Other Assets | $1.24B | 7.1% |
Liabilities Breakdown
Total Liabilities: $10.56B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.21B | 11.4% |
| Long-Term Debt | $7.61B | 72.0% |
| Other Liabilities | $1.75B | 16.6% |